The Changing Face of Oncology Endpoint Monitoring
Learn how PROs provide insights into treatment tolerance and symptom management, complementing traditional tumor response endpoints.
Learn how PROs provide insights into treatment tolerance and symptom management, complementing traditional tumor response endpoints.
Watch the full recording of our webinar on the FDA's draft guidelines for oncology eCOA to prepare for your next study.
Discover the FDA's draft guidance on oncology PROs and its impact on trial design, data collection, patient experience, and outcomes.